A Case of Anti-TNFα Therapies Induced Lupus Panniculitis Successfully Improved With a JAK Inhibitor (Baricitinib)

被引：0

作者：

Grechin, Cristina ^{[1
]}

Doheny, Jane ^{[2
]}

Pilson, Keith ^{[2
]}

Howard, Donough ^{[3
]}

Roche, Muireann ^{[1
]}

机构：

[1] Beaumont Hosp, Dermatol Dept, Dublin, Ireland

[2] Beaumont Hosp, Histopathol Dept, Dublin, Ireland

[3] Beaumont Hosp, Rheumatol Dept, Dublin, Ireland

来源：

JEADV CLINICAL PRACTICE | 2025年

关键词：

anti-TNF-alpha therapies; JAK inhibitor; lupus panniculitis; rheumatoid arthritis; ADALIMUMAB;

D O I：

10.1002/jvc2.626

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (1%-3% of CLE). There are two case reports to date in the literature of LEP potentially triggered by anti-TNF-alpha therapies. Clinically, it is characterised by tender, erythematous subcutaneous indurated nodules or plaques on fatty body areas. It can occur frequently alone or in combination with systemic erythematous lupus or discoid lupus. The pathogenic mechanism of anti-TNF-alpha therapies induced lupus panniculitis is not well understood. Our case report and literature review highlight that anti-TNF-alpha therapies can induce lupus panniculitis, especially in the rheumatoid arthritis cohort of patients.

引用

页数：4

共 50 条

[21] JAK inhibitors in combination with anti-TNF drugs on difficult-to-treat chronic polyarthritis: a case series
Leal, S.
Ivorra-Cortes, J.
De La Rubia-Navarro, M.
Pavez-Perales, C.
RiEsco-BaRcENA, C.
RoMaN-IvoRRA, J. A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (05) : 1135 - 1136
[22] Anti-TNFα drug-induced lupus:: Report of three cases and review of the literature.
Costa, Michelle
Said, Nuha
Zimmermann, Bernard
ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4087 - 4087
[23] Characterization and Outcome of Patients With Infliximab Induced Lupus Erythematosus and Retreatment With a Second Anti-TNF Agent
Subramanian, Sreedhar
Sands, Bruce E.
Yajnik, Vijay
Korzenik, Joshua R.
Cullen, Garret
GASTROENTEROLOGY, 2010, 138 (05) : S61 - S61
[24] Anti-TNFα induced lupus due to infliximab therapy in a patient with concurrent Crohn's disease
Sharma, Akanksha
Ahmed, Taha
Mehta, Aashna
Birnbaum, Julius
Shrestha, Abhigan Babu
CLINICAL CASE REPORTS, 2023, 11 (07):
[25] Anti-TNF-α drug-induced lupus: A Case Report
Alshahrani, Abdulaziz Saad
WORLD FAMILY MEDICINE, 2020, 18 (06): : 81 - 84
[26] PSORIATIC ARTHRITIS SUCCESSFULLY TREATED WITH USTEKINUMAB AFTER ANTI-TNF-ALPHA-INDUCED LUPUS SYNDROME
Lee, Martin
Haigh, Richard C.
RHEUMATOLOGY, 2011, 50 : 48 - 48
[27] Anti-TNF & alpha; induced lupus due to infliximab therapy in a patient with concurrent Crohn's disease
Sharma, Akanksha
Ahmed, Taha
Mehta, Aashna
Birnbaum, Julius
Shrestha, Abhigan Babu
CLINICAL CASE REPORTS, 2023, 11 (07):
[28] Anti-tnf induced lupus-like disease and progressive multifocal leukoencephalopathy: a unifying underlying mechanism?
Papadopoulos, V.
Mavragani, C.
Argyrakos, T.
Velonakis, G.
Stranjalis, G.
Stefanis, L.
Kilidireas, C.
Evangelopoulos, M. E.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 326 - 326
[29] Haploinsufficiency of A20 caused by a novel pathogenic missense variant of TNFAIP3 and successfully treated with anti-TNF and immunosuppressive therapies
Sun, Lina
Han, Ya'nan
Yang, Ying
Wang, Fengfan
Hou, Xin
Ren, Xiaoxia
Fang, Ying
CELLULAR IMMUNOLOGY, 2023, 391
[30] Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model
Ale, Albert
Bruna, Jordi
Morell, Marta
van de Velde, Helgi
Monbaliu, Johan
Navarro, Xavier
Udina, Esther
EXPERIMENTAL NEUROLOGY, 2014, 253 : 165 - 173

← 1 2 3 4 5 →